Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-β

Annals of Hematology

Volumn 83, Issue 5, 2004, Pages 322-325

  Matsunaga, T ^a   Takemoto, N ^a   Miyajima, N ^a   Okuda, T ^a   Nagashima, H ^a   Sato, T ^a   Terui, T ^a   Sasaki, H ^b   Ohmi, N ^b   Hirayama, Y ^c   Tamura, Y ^a   Niitsu, Y ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Otaru Hospital   (Japan)

^c Sapporo Higashi High School   (Japan)

Author keywords

Myelofibrosis; Splenic marginal zone lymphoma; TGF

Indexed keywords

COLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

AGED; ANEMIA; ARTICLE; BLOOD ANALYSIS; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CASE REPORT; COLLAGEN SYNTHESIS; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); FEMALE; FEVER; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; LYMPHOMA CELL; MALAISE; MYELOFIBROSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTOPENIA; TUMOR CELL;

AGED; BONE MARROW CELLS; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MYELOFIBROSIS; SPLEEN; SPLENIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 2342616753     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0806-y     Document Type: Article

References (14)

1. Gralnick HR, Harbor J, Vogel C (1971) Myelofibrosis in chronic granulocytic leukemia. Blood 37:152-162
2. San Miguel JF, Gonzalez M, Canizo MC, Ojeda E, Orfao A, Caballero MD, Moro MJ, Fisac P, Lopez Borrasca A (1988) Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics. Blood 72:402-407
3. Burthem J, Cawley JC (1994) The bone marrow fibrosis of hairy cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by the hairy cells. Blood 83:497-504
4. Burstein SA, Malpass TW, Yee E, Kadin M, Brigden M, Adamson JW, Harker LA (1984) Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis. Br J Haematol 57:383-392
5. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H (1990) The production of transforming growth factor-beta in acute megakaryocytic leukemia and its possible implication in myelofibrosis. Blood 75:1540-1548
6. Dalley A, Smith JM, Reilly JT, Neil SM (1996) Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation. Br J Haematol 93:856-862
7. Rameshwar P, Chang VT, Gascon P (1996) Implication of CD44 in adhesion-mediated overproduction of TGF-beta and IL-1 in monocytes from patients with bone marrow fibrosis. Br J Haematol 93:22-29
8. Martyre MC, Le Bousse-Kerdiles MC, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B (1997) Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97:441-448
9. Sakamaki S, Hirayama Y, Ohi S, Kuga T, Kuroda H, Niitsu Y (1997) Retardation of platelet recovery after peripheral blood stem cell transplantation is due to the decrease of bone marrow stromal thrombopoietin (abstract). Blood 90 [Suppl 1]:141a
10. Hamada T, Yonetani N, Ueda C, Maesako Y, Akasaka H, Akasaka T, Ohno H, Kawakami K, Amakawa R, Okuma M (1998) Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma. Br J Haematol 102:691-700
11. Manoharan A, Horsley R, Pitney WR (1979) The reticulin content of bone marrow in acute leukaemia in adults. Br J Haematol 43:185-190
12. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392
13. Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA, Salles G, Callet-Bauchu E, Coiffier B (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95:1950-1956
14. Morrison AM, Jager U, Chott A, Schebesta M, Haas OA, Busslinger M (1998) Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood 92:3865-3878